|
|
||||||||
Department of Radiology, University of Medicine and Dentistry of New Jersey, Newark New Jersey
Department of Physics and Astronomy, University of Massachusetts, Amherst, Massachusetts
Correspondence: For correspondence and reprints, contact: Dandamudi V. Rao, PhD, Dept of Radiology, Division of Radiation Research, MSB F-451, UMDNJ-New Jersey Medical School, 185 South Orange Ave., Newark, NJ 07103.
ABSTRACT
The capacity of vitamin C (ascorbic acid) to mitigate radiation damage resulting from the tissue-incorporated radionuclide 131I is examined. Spermatogenesis in mice is the experimental model and spermhead survival is the biological endpoint. When a small nontoxic amount of vitamin C was injected, followed by a similar injection of 131I, the 37% spermhead survival dose (D37) increased by a factor of 2.2 compared with the D37 in animals receiving only the radionuclide. Similar radioprotection was also observed when the animals were maintained on a diet enriched with 1% vitamin C (by weight). These results suggest that vitamin C may play an important role as a radioprotector against accidental or medical radiation exposures, especially when radionuclides are incorporated in the body and deliver the dose in a chronic fashion.
This article has been cited by other articles:
![]() |
T. T. Turner and J. J. Lysiak Oxidative Stress: A Common Factor in Testicular Dysfunction J Androl, September 1, 2008; 29(5): 488 - 498. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |